Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens.

Current Opinion in Pharmacology
Murugesan VanangamudiVigneshwaran Namasivayam

Abstract

The non-nucleoside reverse transcriptase inhibitors (NNRTIs) are allosteric inhibitors of HIV-1 reverse transcriptase and are classified into generations depending on their discovery and resistance profiles. The NNRTIs are used in combination regimens with antiretroviral agents that target two or more enzymes in the viral life cycle. The combination regimens usually include a backbone of two nucleoside or nucleotide reverse transcriptase inhibitors and a third core agent among the NNRTIs or protease inhibitors. The combination regimens are maintained over long durations and consequently lead to long-term problems, including toxicity, drug-drug interactions, and increasing costs. This brief overview summarizes the pharmacokinetic profiles for NNRTIs and NNRTI-based combination regimens.

References

Jan 8, 1999·Drugs·J C Adkins, S Noble
Jan 11, 2001·Drugs·L J Scott, C M Perry
May 1, 2001·Clinical Pharmacokinetics·J Q TranB M Kerr
Feb 20, 2007·HIV Medicine·C L Cooper, R P G van Heeswijk
Jan 27, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Raghda K Elsayed, David J Caldwell
Jul 24, 2012·JAMA : the Journal of the American Medical Association·Melanie A ThompsonPaul A Volberding
Sep 13, 2013·Journal of Medicinal Chemistry·Roberto Di Santo
Aug 20, 2014·Infectious Diseases and Therapy·Thibault Mesplède, Mark A Wainberg
Oct 29, 2015·Journal of Medicinal Chemistry·Peng ZhanXinyong Liu
Jan 10, 2016·The Journal of Antimicrobial Chemotherapy·Josep M LlibreJosep M Gatell
Jul 13, 2016·JAMA : the Journal of the American Medical Association·Huldrych F GünthardPaul A Volberding
Oct 5, 2016·Clinical Pharmacokinetics·Matt S AndersonJoan R Butterton
Jan 17, 2017·AIDS Research and Human Retroviruses·Leonardo CalzaPierluigi Viale
Sep 25, 2017·Drugs·Zaina T Al-Salama
Mar 21, 2018·Expert Opinion on Pharmacotherapy·Margaret R CaplanKatya C Corado
May 9, 2018·Expert Opinion on Emerging Drugs·Mohammad A RaiCarl J Fichtenbaum
Jul 26, 2018·JAMA : the Journal of the American Medical Association·Michael S SaagPaul A Volberding
Nov 6, 2018·Expert Review of Anti-infective Therapy·Martina ProperziEugenia Quiros-Roldan
Nov 23, 2018·Drug Design, Development and Therapy·Katya C CoradoEric S Daar
Dec 6, 2018·Journal of Medicinal Chemistry·Vigneshwaran NamasivayamSiddappa N Byrareddy
Jan 11, 2019·Journal of Neurovirology·Gabriele ArendtOlaf Stüve
Apr 3, 2019·Journal of Medicinal Chemistry·Erik De Clercq
May 11, 2019·Journal of the International AIDS Society·Robert GlaubiusUme L Abbas
Jul 22, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Pan-Fen WangEvan D Kharasch
Aug 8, 2019·Clinical Pharmacokinetics·Alison BoyleSaye Khoo
Aug 20, 2019·Current Topics in Medicinal Chemistry·Kenji MaedaHiroaki Takeuchi
Nov 5, 2019·Clinical Pharmacokinetics·Joshua P HavensCourtney V Fletcher
Jan 15, 2020·Current Opinion in Structural Biology·Francesc Xavier Ruiz, Eddy Arnold
Jul 10, 2020·Acta Pharmaceutica Sinica. B·Chunlin ZhuangFener Chen

❮ Previous
Next ❯

Citations

Dec 29, 2020·Current Opinion in Pharmacology·Leonor Huerta

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved